Skip to search.
 FTSE 100 Down 0.80%

More On GLAXF

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

GlaxoSmithKline plc (GLAXF)

-Other OTC
22.74 Up 0.18(0.80%) 29 May 15:26
Add to Portfolio
Prev Close:22.10
Open:22.05
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:22.74 - 22.74
52wk Range:20.50 - 27.67
Volume:320
Avg Vol (3m):2,584
Market Cap:N/A
P/E (ttm):6.90
EPS (ttm):3.29
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):0.25
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :81.74
Quarterly EPS Est (Jun-15) :16.20
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):3.48

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback